Effect of semax peptide on survival of cultured rat pheochromocytoma cells during oxidative stress

Bulletin of Experimental Biology and Medicine

Volumn 135, Issue 3, 2003, Pages 268-271

  Safarova, E R ^a   Shram, S I ^a   Zolotarev, Yu A ^a   Myasoedov, N F ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

Author keywords

Brain ischemia; Cell culture; Necrosis; Oxidative stress; Rat pheochromocytoma PC12; Semax

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; FLUORESCENT DYE; HYDROGEN PEROXIDE; OLIGOPEPTIDE; PROPIDIUM IODIDE; SEMAX; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL DEATH; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG EFFECT; NERVE CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHEOCHROMOCYTOMA CELL; RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT DYES; HYDROGEN PEROXIDE; NECROSIS; NEUROPROTECTIVE AGENTS; OXIDANTS; OXIDATIVE STRESS; PC12 CELLS; PEPTIDE FRAGMENTS; RATS;

ANIMALIA;

EID: 0043198574     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024141232307     Document Type: Article

References (14)

1. I. P. Ashmarin, V. N. Nezavibat'ko, N. F. Myasoedov, et al., Zh. Vyssh. Nervn. Deyat., 47, No. 2, 420-430 (1997).
2. I. A. Grivennikov, O. V. Dolotov, and Yu. I. Gol'dina, Mol. Biol., 33, No. 1, 120-126 (1999).
3. E. I. Gusev and V. I. Skvortsova, Brain Ischemia Brain Ischemia [in Russian], Moscow (2001).
4. E. I. Gusev, V. I. Skvortsova, N. F. Myasoedov, et al., Zh. Nevrol. Psikhiatr., No. 6, 26-34 (1997).
5. O. V. Dolotov, L. S. Inozemtseva, L. A. Andreeva, et al., "Prospects of Physicochemical Biology", Proceedings of Workshop [in Russian], Pushchino (2000), vol. 1, p. 236.
6. A. Ya. Kaplan, V. B. Koshelev, and V. N. Nezavibat'ko, Fiziol. Chel., 18, No. 5, 104-107 (1992).
7. N. F. Myasoedov, V. I. Skvortsova, E. L. Nasonov, et al., Zh. Nevrol. Psikhiatr., No. 5, 15-19 (1997).
8. E. R. Safarova, S. I. Shram, I. A. Grivennikov, and N. F. Myasoedov, Byull. Eksp. Biol. Med., 133, No. 4, 462-465 (2002).
9. V. G. Bashkatova, V. B. Koshelev, O. E. Fadyukova, et al., Brain Res., 894, No. 1, 145-149 (2001).
10. D. B. Hinshaw, M. T. Miller, G. M. Omann, et al., Ibid., 615, No. 1, 13-26 (1993).
11. P. Lipton, Physiol. Rev., 79, No. 4, 1431-1568 (1999).
12. S. Love, Brain Pathol., 9, No. 1, 119-131 (1999).
13. V. N. Potaman, L. Y. Alfeeva, A. A. Kamensky, and V.N. Nezavibatko, Peptides, 14, No. 3, 491-495 (1993).
14. M. I. Shadrina, O. V. Dolotov, I. A. Grivennikov, et al., Neurosci. Lett., 308, No. 2, 115-118 (2001).